Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.
Atik
O Sahap
OS
Department of Orthopedics and Traumatology, Medicine Faculty of Gazi University, Ankara, Turkey. satikmd@gmail.com
Suluova
Fatih
F
Görmeli
Gökay
G
Yildirim
Ahmet
A
Ali
Ali Kh
AKh
D000368:Aged; D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005264:Femoral Fractures / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy; D011859:Radiography; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D019386:Alendronate